Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -51.51 | 10.26 |
| PEG Ratio (TTM) | 0.30 | -1.38 |
| P/S Ratio (TTM) | 0.02 | 0.43 |
| P/B Ratio (TTM) | 0.78 | 2.73 |
| P/FCF Ratio (TTM) | 1.70 | 3.48 |
| Price to 5YR AVG Earnings Ratio | 22.86 | 13.07 |
| Price to 5YR AVG FCF Ratio | 6.24 | 25.47 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.37% | 6.84% |
| ROE (TTM) | -1.46% | 31.67% |
| Net Profit Margin (TTM) | -0.05% | 3.70% |
| ROIC 5YR AVG | 5.72% | 17.33% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -70.57% | 399.23% | 207.67% |
| Revenue | 4.22% | 19.34% | 21.16% |
| Net Income | -67.56% | 395.19% | 204.20% |
| Cash Flow | 39.95% | 47.19% | 35.66% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.06 | 1.45 |
| Quick Ratio (TTM) | 0.97 | 0.97 |
| D/E Ratio (TTM) | 0.27 | 0.79 |
| Interest Coverage (TTM) | 0.35 | 8.46 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 8.21 | 3.37 |
| LTL to 5YR AVG FCF | 1.75 | 7.48 |
| Shares Outstanding Growth 5YR AVG | -8.26% | -0.62% |